From the Ottawa Citizen:
A Canadian-led international study of patients with advanced colorectal cancer has added "one more tool" for them: a drug that extends their lives by an average of six weeks, and which may also help to cure patients if it's used early in the disease.
So far, Cetuximab has only been tested in patients for whom all other treatments have failed. Their cancer has spread, and chemotherapy no longer helps.
The patients in the study lived an average of six months on the drug Cetuximab as opposed to an average of four and a half months without it. However, while it helped 31 per cent of them significantly, it didn't help the rest at all. A mutation in one gene appears to make the difference. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment